Quest Diagnostics Inventory Turnover Ratio 2010-2025 | DGX

Current and historical inventory turnover ratio for Quest Diagnostics (DGX) from 2010 to 2025. Inventory turnover ratio can be defined as a ratio showing how many times a company's inventory is sold and replaced over a period. Quest Diagnostics inventory turnover ratio for the three months ending March 31, 2025 was 9.47.
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $20.053B $9.872B
Quest Diagnostics, Inc. is the provider of commercial laboratory services. Quest provides lab testing services to physicians, hospitals, managed care organizations, employers, government institutions and other clinical laboratories. The company consists of 2 business groups - Diagnostic Information Services and Diagnostic Solutions. The company's focus is on two elements - to accelerate growth and to drive operational excellence. Restore Growth: The company has adopted seven tactical approaches to accelerate growth such as sales and marketing; development of esoteric testing through a disease focus; partnerships with hospitals and successful testing of international IDNs; creation of value from information assets; leadership in companion diagnostics; extension into adjacent markets. Drive Operational excellence: The company plans to focus on four strategic requirements - to enhance end-to-end customer value chain, enterprise information technology architecture, business performance tools and cost excellence.
Stock Name Country Market Cap PE Ratio
Encompass Health (EHC) United States $12.361B 26.20
DaVita (DVA) United States $10.755B 15.12
Chemed (CHE) United States $7.124B 22.39
Elanco Animal Health (ELAN) United States $7.092B 15.19
Option Care Health (OPCH) United States $5.319B 23.71
RadNet (RDNT) United States $4.270B 271.00
Amedisys (AMED) United States $3.229B 21.72
Addus HomeCare (ADUS) United States $2.119B 23.27
LifeStance Health (LFST) United States $2.010B 0.00
Astrana Health (ASTH) United States $1.395B 34.56
U.S Physical Therapy (USPH) United States $1.188B 30.67
Pennant (PNTG) United States $1.029B 37.78
Aveanna Healthcare Holdings (AVAH) United States $1.020B 58.11
Atai Life Sciences (ATAI) Germany $0.439B 0.00
Daxor (DXR) United States $0.047B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.040B 0.00
Ontrak (OTRK) United States $0.002B 0.00
Psychemedics (PMD) United States $0.000B 0.00